PGNY - Progyny Inc Stock Price, Fair Value and News

27.29USD-0.26 (-0.94%)Delayed as of 17 May 2024, 11:54 am ET

Market Summary

USD27.29-0.26

Delayedas of 17 May 2024, 11:54 am

-0.94%

PGNY Alerts

1 major insider sales recently.

PGNY Stock Price

View Fullscreen

PGNY RSI Chart

PGNY Valuation

Market Cap

2.6B

Price/Earnings (Trailing)

42.82

Price/Sales (Trailing)

2.37

EV/EBITDA

30.42

Price/Free Cashflow

13.78

PGNY Price/Sales (Trailing)

PGNY Profitability

EBT Margin

6.94%

Return on Equity

10.72%

Return on Assets

7.71%

Free Cashflow Yield

7.26%

PGNY Fundamentals

PGNY Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

7.62%

Rev. Growth (Qtr)

3.01%

PGNY Earnings

Earnings (TTM)

61.3M

Earnings Growth (Yr)

-4.41%

Earnings Growth (Qtr)

25.45%

Breaking Down PGNY Revenue

52 Week Range

27.0144.95

(Low)(High)

Last 7 days

-15.3%

Last 30 days

-17.5%

Last 90 days

-32.5%

Trailing 12 Months

-22.4%

How does PGNY drawdown profile look like?

PGNY Financial Health

Current Ratio

3.31

PGNY Investor Care

Shares Dilution (1Y)

0.86%

Diluted EPS (TTM)

0.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.1B	0	0	0
2023	873.1M	957.5M	1.0B	1.1B
2022	550.7M	617.1M	700.1M	786.9M
2021	386.0M	450.0M	473.4M	500.6M
2020	263.5M	271.9M	309.7M	344.9M
2019	130.3M	160.3M	193.7M	229.7M
2018	62.8M	77.0M	91.2M	105.4M
2017	0	0	0	48.6M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Progyny Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 23, 2024	payson norman	sold	-11,258	56.29	-200	-
May 01, 2024	sturmer michael e	sold	-144,254	31.95	-4,515	president
Apr 01, 2024	livingston mark s.	acquired	81,476	3.95	20,627	chief financial officer
Apr 01, 2024	livingston mark s.	sold (taxes)	-436,320	37.643	-11,591	chief financial officer
Apr 01, 2024	livingston mark s.	sold	-419,979	37.6157	-11,165	chief financial officer
Apr 01, 2024	schlanger david j	sold (taxes)	-102,280	38.15	-2,681	executive chairman
Apr 01, 2024	anevski peter	sold (taxes)	-304,323	38.15	-7,977	chief executive officer
Apr 01, 2024	schlanger david j	acquired	3,950	3.95	1,000	executive chairman
Apr 01, 2024	schlanger david j	sold	-37,522	37.5225	-1,000	executive chairman
Apr 01, 2024	sturmer michael e	sold	-240,452	37.6	-6,395	president

Which funds bought or sold PGNY recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	Point72 Asset Management, L.P.	new	-	20,935,000	20,935,000	0.05%
May 15, 2024	Cetera Advisor Networks LLC	reduced	-10.9	-23,923	255,224	-%
May 15, 2024	Gotham Asset Management, LLC	sold off	-100	-1,252,000	-	-%
May 15, 2024	NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC	added	0.26	19,824	709,476	0.02%
May 15, 2024	Nippon Life Global Investors Americas, Inc.	added	126	519,184	912,548	0.04%
May 15, 2024	Engineers Gate Manager LP	sold off	-100	-900,871	-	-%
May 15, 2024	ZACKS INVESTMENT MANAGEMENT	added	18.73	237,425	1,324,890	0.01%
May 15, 2024	AMUNDI	unchanged	-	-50,867	278,631	-%
May 15, 2024	SILVERCREST ASSET MANAGEMENT GROUP LLC	added	13.97	3,626,430	25,031,700	0.17%
May 15, 2024	CITADEL ADVISORS LLC	reduced	-33.13	-4,983,460	10,893,700	-%

Are Funds Buying or Selling PGNY?

Are funds buying PGNY calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own PGNY

No. of Funds

PGNY Alerts

1 major insider sales recently.

Unveiling Progyny Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	kleiner perkins caufield & byers xiii, llc	5.3%	5,074,615	SC 13G/A
Feb 14, 2024	macquarie group ltd	1.54%	1,481,588	SC 13G/A
Feb 13, 2024	tpg gp a, llc	7.2%	6,903,267	SC 13G/A
Feb 13, 2024	vanguard group inc	8.63%	8,270,153	SC 13G/A
Jan 23, 2024	blackrock inc.	12.6%	12,111,570	SC 13G/A
Feb 14, 2023	macquarie group ltd	5.37%	4,988,789	SC 13G/A
Feb 14, 2023	alger associates inc	2.6%	2,372,711	SC 13G/A
Feb 10, 2023	tpg gp a, llc	10.5%	9,815,351	SC 13G/A
Feb 09, 2023	vanguard group inc	7.91%	7,345,124	SC 13G/A
Jan 06, 2023	blackrock inc.	10.1%	9,346,854	SC 13G/A

Recent SEC filings of Progyny Inc

View All Filings

Date Filed	Form Type	Document
May 10, 2024	10-Q	Quarterly Report
May 09, 2024	8-K	Current Report
May 02, 2024	4	Insider Trading
May 01, 2024	144	Notice of Insider Sale Intent
Apr 12, 2024	ARS	ARS
Apr 12, 2024	DEF 14A	DEF 14A
Apr 12, 2024	DEFA14A	DEFA14A
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading

Peers (Alternatives to Progyny Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	479.9B	379.5B	11.20%	7.55%	31.24	1.26	12.96%	-25.81%
CI	96.4B	206.0B	-2.18%	28.90%	25.01	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	2.85%	17.20%	15.46	1.27	9.59%	-4.59%
CVS	72.2B	360.9B	-16.66%	-17.14%	9.86	0.2	9.07%	78.49%
CNC	41.2B	155.5B	6.71%	14.75%	15.05	0.26	6.34%	84.42%
UHS	12.0B	14.7B	10.86%	33.14%	14.73	0.82	7.99%	19.23%
DVA	12.0B	12.3B	5.19%	38.43%	14.68	0.97	5.77%	58.74%
MID-CAP
CHE	8.6B	2.3B	-6.84%	5.15%	30.33	3.75	5.96%	18.29%
ACHC	6.2B	3.0B	-6.14%	-7.19%	-547.09	2.07	10.92%	-104.06%
AMEH	2.3B	1.5B	8.58%	22.04%	36.93	1.59	19.34%	40.15%
AMN	2.2B	3.5B	3.96%	-38.10%	15.61	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	13.47%	25.04%	27.49	1.66	11.45%	30.74%
BKD	1.4B	3.0B	11.90%	88.00%	-7.82	0.45	4.98%	4.88%
BEAT	55.6M	-	17.22%	-3.21%	-3.68	-	-	-1.05%
AMS	21.1M	21.6M	17.97%	25.63%	38.19	0.98	9.04%	-50.63%

Progyny Inc News

Latest updates

Progyny Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	3.0%	278	270	281	279	258	214	205	195	172	128	122	129	122	100	99.00	65.00	81.00	65.00	61.00	56.00	47.00
Gross Profit	9.7%	62.00	57.00	63.00	61.00	59.00	44.00	46.00	44.00	33.00	25.00	28.00	30.00	29.00	21.00	21.00	12.00	17.00	12.00	12.00	11.00	10.00
Operating Expenses	1.8%	44.00	43.00	44.00	45.00	44.00	41.00	35.00	35.00	33.00	25.00	19.00	18.00	17.00	20.00	16.00	13.00	13.00	11.00	9.00	9.00	7.00
S&GA Expenses	3.6%	15.00	15.00	15.00	15.00	14.00	13.00	11.00	11.00	10.00	8.00	4.00	4.00	4.00	5.00	3.00	4.00	3.00	3.00	3.00	3.00	2.00
EBITDA Margin	6.2%	0.07*	0.07*	0.06*	0.06*	0.05*	0.03*	0.03*	0.03*	0.04*	0.07*	0.08*	0.07*	-	-	-	-	-	-	-	-	-
Interest Expenses	-14.8%	1.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	-0.02	-0.02	0.00	0.00	0.00	-0.03	-0.13	-0.04
Income Taxes	100.6%	6.00	3.00	5.00	2.00	-1.35	1.00	-1.67	0.00	-5.11	-15.48	-7.68	-6.81	-3.37	-37.90	0.00	-0.02	0.00	-0.08	0.00	0.00	-
Earnings Before Taxes	38.5%	23.00	16.00	21.00	17.00	16.00	4.00	12.00	9.00	-0.14	-0.40	9.00	12.00	12.00	1.00	5.00	-1.06	4.00	-4.48	-8.18	2.00	3.00
EBT Margin	6.8%	0.07*	0.06*	0.06*	0.05*	0.05*	0.03*	0.03*	0.03*	0.04*	0.06*	0.07*	0.07*	-	-	-	-	-	-	-	-	-
Net Income	25.4%	17.00	13.00	16.00	15.00	18.00	3.00	13.00	9.00	5.00	15.00	17.00	19.00	15.00	39.00	5.00	-1.06	4.00	-4.40	-8.21	2.00	3.00
Net Income Margin	-3.0%	0.06*	0.06*	0.05*	0.05*	0.05*	0.04*	0.06*	0.07*	0.10*	0.13*	0.19*	0.17*	-	-	-	-	-	-	-	-	-
Free Cashflow	-32.7%	25.00	37.00	53.00	75.00	20.00	51.00	20.00	19.00	-12.05	8.00	23.00	-7.90	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																				(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2018Q4
Assets	5.0%	794	757	727	682	650	543	510	463	416	358	337	312	295	254	202	178	180	150	73.00	41.00
Current Assets	6.4%	682	640	611	561	527	434	402	356	309	259	254	238	228	190	185	160	162	132	53.00	25.00
Cash Equivalents	18.2%	115	97.00	158	171	155	120	73.00	55.00	39.00	91.00	92.00	49.00	30.00	70.00	54.00	49.00	92.00	80.00	8.00	0.00
Net PPE	0.2%	10.00	10.00	10.00	9.00	9.00	8.00	7.00	6.00	6.00	5.00	5.00	4.00	4.00	3.00	4.00	4.00	4.00	3.00	1.00	1.00
Goodwill	0%	12.00	12.00	12.00	12.00	12.00	12.00	12.00	12.00	12.00	12.00	12.00	12.00	12.00	12.00	12.00	12.00	12.00	12.00	12.00	12.00
Liabilities	9.6%	223	203	211	212	225	166	164	152	136	106	113	108	110	87.00	75.00	58.00	59.00	36.00	58.00	30.00
Current Liabilities	10.7%	206	186	193	194	207	160	157	145	129	99.00	104	99.00	101	78.00	74.00	58.00	59.00	36.00	58.00	30.00
Shareholder's Equity	3.3%	572	553	515	469	424	377	347	311	280	252	224	205	185	167	126	119	119	114	-	-
Retained Earnings	18.8%	107	90.00	77.00	61.00	46.00	28.00	25.00	11.00	3.00	-2.42	-17.50	-34.30	-53.03	-68.19	-105	-111	-109	-113	-109	-104
Additional Paid-In Capital	6.0%	489	462	438	409	379	350	323	301	278	255	243	240	239	236	234	232	232	229	19.00	11.00
Shares Outstanding	-0.2%	96.00	96.00	96.00	95.00	94.00	93.00	92.00	92.00	91.00	89.00	90.00	88.00	-	-	-	-	-	-	-	-
Float	-	-	-	-	3,300	-	-	-	2,300	-	-	-	4,100	-	-	-	1,100	-	1,100	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-31.7%	25,732	37,659	54,182	76,012	20,961	51,517	20,894	19,246	-11,262	8,815	24,163	-7,473	532	6,537	15,329	2,197	12,140	-5,489	5,879	4,247	-6,171
Share Based Compensation	7.8%	31,052	28,799	31,251	31,753	30,808	29,297	23,297	23,654	24,500	15,008	7,147	6,517	5,034	4,160	3,071	3,541	2,049	1,852	1,680	1,012	517
Cashflow From Investing	120.7%	19,344	-93,414	-64,315	-58,923	16,127	-1,173	-1,876	-1,259	-39,558	-6,312	22,374	31,224	-38,520	11,887	-9,148	-42,077	-693	-2,278	-420	-133	75.00
Cashflow From Financing	-445.5%	-27,411	-5,025	-2,362	-1,839	-1,846	-2,786	-1,228	-2,078	-1,772	-3,314	-3,060	-4,824	-2,497	-2,084	-1,608	-2,363	-194	80,485	1,907	-4,180	6,333
Buy Backs	-	23,764	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.00	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

PGNY Income Statement

2024-03-31

Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statements of Operations
Revenue	$ 278,078	$ 258,394
Cost of services	215,672	199,754
Gross profit	62,406	58,640
Operating expenses:
Sales and marketing	15,454	14,282
General and administrative	28,429	29,347
Total operating expenses	43,883	43,629
Income from operations	18,523	15,011
Other income, net:
Other income, net	3,360	498
Interest income, net	632	822
Total other income, net	3,992	1,320
Income before income taxes	22,515	16,331
Provision (benefit) for income taxes	5,617	(1,347)
Net income	$ 16,898	$ 17,678
Net income per share:
Basic (in dollars per share)	$ 0.18	$ 0.19
Diluted (in dollars per share)	$ 0.17	$ 0.18
Weighted-average shares used in computing net income per share:
Basic (in shares)	96,484,657	93,832,873
Diluted (in shares)	101,052,933	100,166,008

PGNY Balance Sheet

2024-03-31

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 114,959	$ 97,296
Marketable securities	256,872	273,791
Accounts receivable, net of $50,054 and $46,636 of allowances at March 31, 2024 and December 31, 2023, respectively	297,209	241,869
Prepaid expenses and other current assets	12,472	27,451
Total current assets	681,512	640,407
Property and equipment, net	10,234	10,213
Operating lease right-of-use assets	17,181	17,605
Goodwill	11,880	11,880
Deferred tax assets	70,269	73,120
Other noncurrent assets	3,228	3,395
Total assets	794,304	756,620
Current liabilities:
Accounts payable	130,171	125,426
Accrued expenses and other current liabilities	75,748	60,524
Total current liabilities	205,919	185,950
Operating lease noncurrent liabilities	16,781	17,241
Total liabilities	222,700	203,191
Commitments and Contingencies (Note 6)
STOCKHOLDERS' EQUITY
Common stock, $0.0001 par value; 1,000,000,000 shares authorized; $96,839,393 and 96,348,522 shares issued; 96,115,816 and 96,348,522 shares outstanding at March 31, 2024 and December 31, 2023, respectively	9	9
Additional paid-in capital	489,343	461,639
Treasury stock, at cost, $0.0001 par value; 1,339,557 and $615,980 shares at March 31, 2024 and December 31, 2023, respectively	(27,367)	(1,009)
Accumulated earnings	106,869	89,971
Accumulated other comprehensive income	2,750	2,819
Total stockholders’ equity	571,604	553,429
Total liabilities and stockholders’ equity	$ 794,304	$ 756,620

About Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

CEO	Mr. Peter Anevski
WEBSITE	progyny.com
INDUSTRY	Healthcare Plans
EMPLOYEES	393

Progyny Inc Frequently Asked Questions

What is the ticker symbol for Progyny Inc? What does PGNY stand for in stocks?

PGNY is the stock ticker symbol of Progyny Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Progyny Inc (PGNY)?

As of Thu May 16 2024, market cap of Progyny Inc is 2.62 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PGNY stock?

You can check PGNY's fair value in chart for subscribers.

What is the fair value of PGNY stock?

You can check PGNY's fair value in chart for subscribers. The fair value of Progyny Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Progyny Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PGNY so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Progyny Inc a good stock to buy?

The fair value guage provides a quick view whether PGNY is over valued or under valued. Whether Progyny Inc is cheap or expensive depends on the assumptions which impact Progyny Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PGNY.

What is Progyny Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 16 2024, PGNY's PE ratio (Price to Earnings) is 42.82 and Price to Sales (PS) ratio is 2.37. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PGNY PE ratio will change depending on the future growth rate expectations of investors.